Aenova Presents New Highlights at Vitafoods
At Vitafoods Europe, which is taking place from 22 to 24 May 2012 in Geneva, the Aenova Group is presenting two new highlights from its range of products and services: CaloriSorb, a class III drug for weight reduction, and an innovative technology for manufacturing three-layer-tablets.
16 May 2012 --- Europe’s leading manufacturer of solid oral dosage forms, the Aenova Group, is exhibiting two innovative products from its portfolio for the first time at Vitafoods in Geneva: CaloriSorb, a class III drug for weight reduction, and a new technology for manufacturing three-layer-tablets.
At Vitafoods Europe, which is taking place from 22 to 24 May 2012 in Geneva, the Aenova Group is presenting two new highlights from its range of products and services: CaloriSorb, a class III drug for weight reduction, and an innovative technology for manufacturing three-layer-tablets. CaloriSorb contains a natural polymer which reduces calorie absorption from dietary fats and helps with weight control. The innovative three-layer technology allows several interactive substances to be combined in a single tablet and each layer to be given a different release profile.
Alongside these innovations, Aenova is exhibiting its high-quality effervescent products and its range of standard products at Vitafoods. The group, which has a strong presence on the global market, provides technologies to meet a wide range of customer requirements, including the manufacture of soft gelatine capsules, tablets and effervescent products. Aenova also offers its customers a complete portfolio of services, ranging from development, production and analysis through to packaging and logistics.
Aenova Holding GmbH was established in 2008 following the merger between two prominent medium-sized companies: Dragenopharm Apotheker Püschl GmbH and SWISS CAPS AG. The Aenova Group is now one of the leading manufacturers and suppliers of medicines and dietary supplements in oral dosage forms, such as soft gelatine capsules, hard capsules, tablets, film-coated tablets, dragées and effervescent tablets for the pharmaceutical and healthcare industry. The group has an annual turnover of around EUR 250 million and employs 1700 people at its sites in Germany (Tittmoning, Berlin, Bad Aibling and Warstein), Switzerland (Kirchberg, Muttenz and Bioggio), France (Lyons), Romania (Cornu) and the USA (Miami). The Aenova Group, which has its headquarters in Pähl, offers its customers a complete portfolio of services, ranging from development, procurement of raw materials, production and analysis through to packaging and logistics.
